Skip to content

Benefits of Nutrition and Physical Activity for the health of people with Kidney Issues

Impact of Nutrition and Exercise on Microbiota, Uremic Toxins and quality of Life in patients with Chronic Kidney Disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-83h7hfm
Enrollment
Unknown
Registered
2025-06-26
Start date
2024-10-11
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Failure, Chronic

Interventions

This study will include approximately 100 individuals diagnosed with Chronic Kidney Disease (CKD), either under conservative treatment or on hemodialysis, recruited from clinics and outpatient service
C12.777.419.780
E02.335.686.400
G02.403.810
G11.427.410
A13.869.161
D23.050.301
I01.880.735.950

Sponsors

Universidade Católica de Brasília
Lead Sponsor
Universidade Católica de Brasília
Collaborator

Eligibility

Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Volunteers diagnosed with chronic kidney disease; age minimum eighteen and age maximum sixty five years; physically inactive.

Exclusion criteria

Exclusion criteria: Smoker volunteers; diagnoses of cardic; gastrointestinal; hepatic; pulmonary; neurological; psychiatric; hematological or metabolic autoimmune diseases; diagnosis of sleep disorders.

Design outcomes

Primary

MeasureTime frame
Renal Function of Patients in Conservative Stage by Estimated Glomerular Filtration Rate (eGFR): Baseline and every two months until the end of the protocol

Secondary

MeasureTime frame
quality of life as secondary measures of SF-36 : Baseline and every two months until the end of the protocol;Improvement in Inflammatory Biomarkers, Renal Health, Cardiovascular Function, and Metabolism: Interleukin 6, Interleukin 10, BDNF, Tumor Necrosis Factor, Nitric Oxide, Lactate, KIM-1, NGAL, Indoxyl Sulfate, p-Cresyl Sulfate, TMAO, TNF-a, IL-6, ADMA, and Leptin: Baseline and every two months until the end of the protocol ;Improvement in Microbiota Diversity and Composition: Microbial DNA Extraction from Feces. Baseline and at the end of the protocol;Improvement in Serum Lipid Levels Assessed by Measurements of Total Cholesterol (TC), LDL-c, HDL-c, and Triglycerides: Baseline, in real-time for 14 days, and two months after the protocol;Blood Glucose Levels Continuously Monitored via the Libre Sensor: Baseline, in real-time for 14 days, and two months after the protocol;Improvement in Physical Fitness Assessed by the Cardiopulmonary Exercise Test (CPET): Baseline and every two months until the end of the protocol ;Isometric Muscle Strength Assessed by Handgrip Strength Test: Baseline and every two months until the end of the protocol ;Score >9 Assessed by the Becker Depression Scale: Baseline and every two months until the end of the protocol

Countries

Brazil

Contacts

Public ContactJessica Barbosa

Universidade Católica de Brasília

jessicamycaelle.nut@gmail.com+5561983181820

Outcome results

None listed

Source: REBEC (via WHO ICTRP)